Table 1.
The association of ZIP transporters with overall survival (OS) and progression-free survival (PFS) in ovarian cancer patients
| Genes | OS | PFS | ||||
|---|---|---|---|---|---|---|
| Patients Number | HR (95 % CI) | Logrank P | Patients Number | HR (95 % CI) | Logrank P | |
| ZIP1 | 1656 | 1.13 (0.97–1.33) | 0.12 | 1435 | 1.16 (1.01–1.33) | 0.037 |
| ZIP2 | 1656 | 0.93 (0.80–1.07) | 0.31 | 1435 | 0.89 (0.78–1.02) | 0.089 |
| ZIP3 | 655 | 1.18 (0.96–1.45) | 0.11 | 614 | 0.86 (0.70–1.05) | 0.14 |
| ZIP4 | 1656 | 0.92 (0.80–1.05) | 0.22 | 1435 | 0.92 (0.81–1.05) | 0.2 |
| ZIP5 | 655 | 1.32 (1.08–1.62) | 0.0066 | 614 | 1.48 (1.23–1.79) | 3.50E-05 |
| ZIP6 | 1656 | 1.08 (0.94–1.25) | 0.29 | 1435 | 0.84 (0.72–0.97) | 0.019 |
| ZIP7 | 1656 | 0.78 (0.67–0.90) | 0.00058 | 1435 | 1.17 (1.03–1.33) | 0.014 |
| ZIP8 | 1656 | 1.06 (0.93–1.21) | 0.37 | 1435 | 0.87 (0.75–1.01) | 0.071 |
| ZIP9 | 655 | 1.18 (0.94–1.48) | 0.15 | 614 | 0.89 (0.74–1.08) | 0.23 |
| ZIP10 | 655 | 1.30 (1.06–1.60) | 0.012 | 614 | 1.28 (1.06–1.55) | 0.009 |
| ZIP11 | 655 | 1.11 (0.90–1.38) | 0.32 | 614 | 0.85 (0.70–1.04) | 0.11 |
| ZIP12 | 655 | 1.24 (1.01–1.54) | 0.044 | 614 | 1.50 (1.22–1.84) | 9.10E-05 |
| ZIP13 | 655 | 1.66 (1.36–2.03) | 7.50E-07 | 614 | 1.90 (1.58–2.30) | 1.10E-11 |
| ZIP14 | 1656 | 1.25 (1.10–1.42) | 0.00066 | 1435 | 1.27 (1.12–1.44) | 2.00E-04 |